Skip to content
Screener

EPS (Diluted) at other companies

AbbVie logo
AbbVieABBV
$2.03+290%
Solesence, Inc. logo
Solesence, Inc.SLSN
$0.00-100%
The Estée Lauder Companies Inc. logo
The Estée Lauder Companies Inc.EL
$0.24-45.5%
NuSkin Enterprises logo
NuSkin EnterprisesNUS
-$5.14-1,295%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
-$0.08-100%
Kenvue logo
KenvueKVUE
$0.24+9.1%

Other financials

Income statement

See full
Revenue$72.1M-7.8%
Gross profit$49.3M+0.5%
Operating income$3.6M+232%
Net income-$2.7M-114%

Balance sheet

See full
Cash & equivalents$206.1M-2.8%
Total debt$124.9M-66.8%
Total equity$55.6M-24.9%
Total assets$486.6M-4.1%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$427.0K+364%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.15M-65.7%
Enterprise value$7.99M-98.1%
P/S0.3×-0.5×

Profitability

See full
Gross margin66.4%+4.9pp
Operating margin-1.5%-0.7pp
Net margin-9.8%+14.7pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-43.9%+82.7pp
Debt / equity2.2×-2.8×
Current ratio1.8×-3.4×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: The Beauty Health Company’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054476
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Foreign currency translation adjustments3133,629354,757
Comprehensive (loss) income$(2,356)$23,341$(9,264)$14,373
Net (loss) income per share
Basic$(0.02)$0.16$(0.07)$0.08
Diluted$(0.02)$0.03$(0.07)$(0.02)
Weighted average common stock outstanding
Basic129,596,886126,072,603128,699,733125,578,780
Diluted129,596,886140,294,291128,699,733140,589,807

Item 1. Financial Statements.

FAQ

What is The Beauty Health Company's EPS (diluted)?
The Beauty Health Company (SKIN) reported EPS (diluted) of -$0.02 in Q2 2026.
How has The Beauty Health Company's EPS (diluted) changed year-over-year?
The Beauty Health Company's EPS (diluted) decreased by 166.7% year-over-year, from $0.03 to -$0.02.
What is the long-term trend for The Beauty Health Company's EPS (diluted)?
Over 4 years (2021 to 2025), The Beauty Health Company's EPS (diluted) has grown at a -52.4% compound annual growth rate (CAGR), from -$3.71 to -$0.19.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about The Beauty Health Company's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude